Ernst & Young (EY US) has announced the finalists for the prestigious Entrepreneur Of The Year 2025 New England Award. Now in its 40th year, the Entrepreneur Of The Year program celebrates the bold ...

Axsome Therapeutics, a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, entered into a $570 million term loan and revolving credit facility with ...

Pyxus International, a global value-added agricultural company, announced the amendment of its asset-based lending (ABL) credit facility with PNC Bank, which was initially established February 8, 2022 ...

Altimmune, a late clinical-stage biopharmaceutical company developing novel peptide-based therapeutics for liver and cardiometabolic diseases, entered into an agreement with Hercules Capital, for up ...

A new NAV-based loan agreement with Hark Capital, providing Fusion Connect with a term loan of $85 million. The proceeds will be used for operating capital, to pay down existing debt, and to drive new ...